Market Place
Sourcing Support
Genelux Joins H.C. Wainwright Fireside Chat Event
13 Dec 2024 //
GLOBENEWSWIRE
Genelux Corporation Reports Q3 2024 Financial Results & Updates
14 Nov 2024 //
GLOBENEWSWIRE
Genelux to Join Fireside Chat at Guggenheim Healthcare Conference
06 Nov 2024 //
GLOBENEWSWIRE
Genelux Doses First Patient In Phase 2 Trial For Lung Cancer
22 Oct 2024 //
GLOBENEWSWIRE
Genelux to Participate in the 2024 Maxim Healthcare Virtual Summit
09 Oct 2024 //
GLOBENEWSWIRE
Genelux Corporation to Present at H.C. Wainwright Global Conference
03 Sep 2024 //
GLOBENEWSWIRE
Genelux Reports Q2 2024 Financial Results And General Business Updates
14 Aug 2024 //
GLOBENEWSWIRE
Genelux To Participate In BTIG Virtual Biotechnology Conference 2024
30 Jul 2024 //
GLOBENEWSWIRE
Genelux $27.5M Public Offering: Common Stock Warrants Pricing Announced
24 May 2024 //
GLOBENEWSWIRE
Genelux Proposed Public Offering: Common Stock And Warrants Announced
23 May 2024 //
GLOBENEWSWIRE
Genelux Reports Q1 2024 Financials And Business Updates
09 May 2024 //
GLOBENEWSWIRE
Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
01 Apr 2024 //
GLOBENEWSWIRE
Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec
27 Nov 2023 //
GLOBENEWSWIRE
Genelux Corporation Reports Third Quarter 2023 Financial Results
14 Nov 2023 //
GLOBENEWSWIRE
Genelux Corp Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 Sep 2023 //
GLOBENEWSWIRE
Genelux to Present at the H.C. Wainwright Global Investment Conference
07 Sep 2023 //
GLOBENEWSWIRE
Genelux Corporation Reports Second Quarter 2023 Financial Results
14 Aug 2023 //
GLOBENEWSWIRE
Genelux to Participate in Fireside Chat at BTIG`s Biotechnology Conference 2023
02 Aug 2023 //
GLOBENEWSWIRE
Genelux Strengthens Senior Management and Clinical Team with New Hires
20 Jul 2023 //
GLOBENEWSWIRE
Genelux Announces Publication of Phase I Trial Results of Intrapleural Administration of Olvi-Vec
10 Jul 2023 //
GLOBENEWSWIRE
Genelux Corporation Announces $18 Million Private Placement
12 Jun 2023 //
GLOBENEWSWIRE
Genelux Announces Publication of Positive Data from Phase 2 VIRO-15 Trial
25 May 2023 //
GLOBENEWSWIRE
Genelux Corporation Announces $33 Million Private Placement
15 May 2023 //
GLOBENEWSWIRE
Genelux Corporation to Ring Nasdaq Opening Bell on March 29, 2023
23 Mar 2023 //
GLOBENEWSWIRE
Genelux Announces Exclusive Out-Licensing Agreement with ELIAS Animal Health
18 Nov 2021 //
BIOSPACE
Genelux Announces Closing of a Strategic Financing Transaction
27 Sep 2020 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.